These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8212272)

  • 1. Teniposide, doxorubicin, melphalan, cisplatin, and total body irradiation with autologous bone marrow transplantation for advanced neuroblastoma.
    Lam-Po-Tang PR; McCowage GB; Vowels MR
    Transplant Proc; 1993 Oct; 25(5):2881-2. PubMed ID: 8212272
    [No Abstract]   [Full Text] [Related]  

  • 2. Autologous bone marrow transplantation for advanced neuroblastoma using teniposide, doxorubicin, melphalan, cisplatin, and total-body irradiation.
    McCowage GB; Vowels MR; Shaw PJ; Lockwood L; Mameghan H
    J Clin Oncol; 1995 Nov; 13(11):2789-95. PubMed ID: 7595740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive chemoradiotherapy and autologous bone marrow transplantation for poor prognosis neuroblastoma.
    Seeger RC; Villablanca JG; Matthay KK; Harris R; Moss TJ; Feig SA; Selch M; Ramsay N; Reynolds CP
    Prog Clin Biol Res; 1991; 366():527-33. PubMed ID: 2068169
    [No Abstract]   [Full Text] [Related]  

  • 4. Autologous bone marrow transplantation for very bad prognosis neuroblastoma.
    Philip T; Biron P; Philip I; Favrot M; Bernard JL; Zucker JM; Lutz B; Plouvier E; Rebattu P; Carton M
    Prog Clin Biol Res; 1985; 175():569-86. PubMed ID: 3887433
    [No Abstract]   [Full Text] [Related]  

  • 5. [Metastatic neuroblastoma: consolidation treatment with 2 courses of high-dose chemotherapy followed by a bone marrow autograft].
    Hartmann O; Benhamou E; Beaujean F; Kalifa C; Lejars O; Patte C; Behard C; Flamant F; Thyss A; Deville A
    Bull Cancer; 1988; 75(1):119-23. PubMed ID: 3282574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of advanced neuroblastoma with two consecutive high-dose chemotherapy regimens and ABMT.
    Hartmann O; Kalifa C; Beaujean F; Bayle C; Benhamou E; Lemerle J
    Prog Clin Biol Res; 1985; 175():565-8. PubMed ID: 3887432
    [No Abstract]   [Full Text] [Related]  

  • 7. A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma.
    Kamani N; August CS; Bunin N; Leahey A; Bayever E; Goldwein J; Zusman J; Evans AE; Angio GD
    Bone Marrow Transplant; 1996 Jun; 17(6):911-6. PubMed ID: 8807093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation.
    Hovi L; Saarinen-Pihkala UM; Vettenranta K; Lipsanen M; Tapanainen P
    Bone Marrow Transplant; 1999 Nov; 24(10):1131-6. PubMed ID: 10578163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of neuroblastoma: role of total body irradiation].
    Franzone P; Corvò R; Dini G; Perin GP; Scarpati D
    Radiol Med; 1986 Dec; 72(12):959-62. PubMed ID: 3541069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intensive chemotherapy followed by autologous bone marrow transplantation in solid tumors in childhood].
    de Kraker J; Voûte PA; Behrendt H
    Ned Tijdschr Geneeskd; 1984 Dec; 128(49):2302-5. PubMed ID: 6392905
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma.
    Valteau-Couanet D; Vassal G; Pondarré C; Bonnay M; Benhamou E; Couanet D; Plantaz D; Hartmann O
    Bone Marrow Transplant; 1996 Apr; 17(4):485-9. PubMed ID: 8722343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relapsed stage I neuroblastoma successfully treated by allogeneic bone marrow transplantation in second remission: case report of a 7-year-old girl].
    Hanada R; Yaginuma A; Hayashi Y; Inaba T; Yamamoto K; Imaizumi S; Hirata A; Sugawara T; Aihara T; Miyakawa T
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1937-9. PubMed ID: 2203317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of myeloablative therapy with bone marrow transplantation in advanced neuroblastoma.
    Matthay KK
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S21-4. PubMed ID: 8971402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma.
    Hartmann O; Benhamou E; Beaujean F; Kalifa C; Lejars O; Patte C; Behard C; Flamant F; Thyss A; Deville A
    J Clin Oncol; 1987 Aug; 5(8):1205-11. PubMed ID: 3305792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous bone marrow transplantation for stage IV neuroblastoma: the role of soybean agglutinin purging.
    Kapelushnik J; Nagler A; Or R; Naparstek E; Cividalli G; Aker M; Mehta J; Mumcuoglu M; Slavin S
    Transplant Proc; 1993 Jun; 25(3):2375-6. PubMed ID: 8516934
    [No Abstract]   [Full Text] [Related]  

  • 16. A single center experience with bone marrow transplantation for high risk neuroblastoma.
    Ladenstein R; Lasset C; Bouffet E; Brunat-Mentigny M; Biron P; Philip I; Chauvin F; Philip T
    Bone Marrow Transplant; 1991; 7 Suppl 2():93. PubMed ID: 1878741
    [No Abstract]   [Full Text] [Related]  

  • 17. [Massive chemotherapy and purged bone marrow autograft in severe neuroblastoma. Preliminary results apropos of 5 cases].
    Frappaz D; Philip T; Philip I; Biron P; Bouffet E; Favrot M; Veley B; Martinez MF; Lacroze M; Dutou L
    Pediatrie; 1985; 40(7):539-51. PubMed ID: 3913896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group.
    Matthay KK; Seeger RC; Reynolds CP; Stram DO; O'Leary MC; Harris RE; Selch M; Atkinson JB; Haase GM; Ramsay NK
    J Clin Oncol; 1994 Nov; 12(11):2382-9. PubMed ID: 7964954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloablative combination chemotherapy without total body irradiation for neuroblastoma.
    Kushner BH; O'Reilly RJ; Mandell LR; Gulati SC; LaQuaglia M; Cheung NK
    J Clin Oncol; 1991 Feb; 9(2):274-9. PubMed ID: 1899111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic neuroblastoma managed by supralethal therapy and bone marrow reconstitution (BMRc). Results of a four-institution Children's Cancer Study Group pilot study.
    D'Angio GJ; August C; Elkins W; Evans AE; Seeger R; Lenarsky C; Feig S; Wells J; Ramsay N; Kim T
    Prog Clin Biol Res; 1985; 175():557-63. PubMed ID: 3887431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.